Details of the Drug

General Information of Drug (ID: DMMNZEJ)

Drug Name

SID-530

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00931008) Study to Evaluate SID 530 Compared to Taxotere. U.S. National Institutes of Health.